Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

UNIVERSITY OF PATRAS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1964-01-01

Employees: -

Market Cap: -

Website: http://www.upatras.gr

Clinical Trials

Differential Effect of Ticagrelor Versus Prasugrel Maintenance Dose on Endothelial Function of Peripheral Vessels in Patients With Coronary Artery Disease

Phase 4

Completed

Conditions: Endothelial Function
Coronary Artery Disease

Interventions: Drug: Ticagrelor
Drug: Prasugrel

First Posted Date: 2013-10-08

Last Posted Date: 2017-01-10

Lead Sponsor: University of Patras

Target Recruit Count: 22

Registration Number: NCT01957540

Locations: 🇬🇷
Patras University Hospital, Patras, Achaia, Greece

Offset of Ticagrelor's Effect on Endothelial Function as Assessed With Peripheral Arterial Tonometry (EndoPAT Assay)

Completed

Conditions: Endothelial Function
Coronary Artery Disease

Interventions: Device: Peripheral arterial tonometry (EndoPAT)

First Posted Date: 2013-10-08

Last Posted Date: 2015-08-20

Lead Sponsor: University of Patras

Target Recruit Count: 30

Registration Number: NCT01957527

Locations: 🇬🇷
Patras University Hospital, Patras, Achaia, Greece

Ticagrelor vs High Dose Clopidogrel in Patients With ST Elevation Myocardial Infarction Post Fibrinolysis

Phase 4

Completed

Conditions: ST Elevation Myocardial Infarction
Fibrinolysis
P2Y12 Inhibitor

Interventions: Drug: Ticagrelor 180mg loading dose and 90mg bid maintenance dose
Drug: Clopidogrel 600mg loading dose and 150mg maintenance dose

First Posted Date: 2013-09-25

Last Posted Date: 2015-08-20

Lead Sponsor: University of Patras

Target Recruit Count: 56

Registration Number: NCT01950416

Locations: 🇬🇷
Konstantopoulio General Hospital of Athens, Athens, Attiki, Greece
🇬🇷
Patras University Hospital, Patras, Greece

High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)

Phase 3

Completed

Conditions: Platelet Reactivity

Interventions: Drug: Prasugrel 100mg loading dose
Drug: Prasugrel 60mg loading dose

First Posted Date: 2013-04-18

Last Posted Date: 2013-09-23

Lead Sponsor: University of Patras

Target Recruit Count: 82

Registration Number: NCT01835353

Locations: 🇬🇷
Dimitrios Alexopoulos, Patras, Achaia, Greece

The GReek AntiPlatElet (GRAPE) Registry: A Multicenter Observational Prospective Investigation of Antiplatelet Treatment in Patients With Acute Coronary Syndrome Subjected to Percutaneous Coronary Intervention

Completed

Conditions: Acute Coronary Syndrome

First Posted Date: 2013-01-24

Last Posted Date: 2015-08-20

Lead Sponsor: University of Patras

Target Recruit Count: 2047

Registration Number: NCT01774955

Locations: 🇬🇷
Patras University Hospital, Patras, Achaia, Greece
🇬🇷
G.Gennimatas General Hospital, Athens, Attica, Greece
🇬🇷
University Hospital, Alexandroupolis, Alexandroupolis, Greece

and more 6 locations

High on Treatment Platelet Reactivity Following Peripheral Endovascular Procedures

Completed

Conditions: Influence of PRU Values on Primary Outcome

First Posted Date: 2012-12-06

Last Posted Date: 2013-01-14

Lead Sponsor: University of Patras

Target Recruit Count: 100

Registration Number: NCT01744613

Locations: 🇬🇷
Patras University Hospital, Rion, Achaia, Greece

Differential Effect of Ticagrelor Versus Prasugrel on the Adenosine-induced Coronary Vasodilatory Responses in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Phase 4

Completed

Conditions: Acute Coronary Syndrome

Interventions: Drug: Prasugrel
Drug: Ticagrelor

First Posted Date: 2012-07-17

Last Posted Date: 2013-01-23

Lead Sponsor: University of Patras

Target Recruit Count: 56

Registration Number: NCT01642966

Locations: 🇬🇷
Cardiology Department Patras University Hospital, Patras, Achaia, Greece

Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic Study

Phase 4

Completed

Conditions: Coronary Artery Disease
Acute Coronary Syndrome

Interventions: Drug: Prasugrel
Drug: Ticagrelor

First Posted Date: 2012-07-17

Last Posted Date: 2013-01-23

Lead Sponsor: University of Patras

Target Recruit Count: 30

Registration Number: NCT01642940

Locations: 🇬🇷
Cardiology Department Patras University Hospital, Patras, Achaia, Greece

Comparative Study of Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Morbidly Obese Patients

Phase 2

Conditions: Morbid Obesity
Neuromuscular Blockade

Interventions: Drug: Neostigmine
Drug: Sugammadex

First Posted Date: 2012-06-27

Last Posted Date: 2012-06-27

Lead Sponsor: University of Patras

Target Recruit Count: 120

Registration Number: NCT01629394

Locations: 🇬🇷
University of Patras, Department of Anesthesiology and Critical Care Medicine, Patras, Achaia, Greece

Subarachnoid Administration of Levobupivacaine for Cesarean Section

Phase 2

Conditions: Stillborn Caesarean Section

Interventions: Drug: ropivacaine plain +. fentanyl
Drug: Bupivacaine plain
Drug: Ropivacaine plain
Drug: Levobupivacaine plain
Drug: bupivacaine plain +fentanyl
Drug: Levobupivacaine plain +fentanyl

First Posted Date: 2012-04-20

Last Posted Date: 2012-04-20

Lead Sponsor: University of Patras

Target Recruit Count: 130

Registration Number: NCT01582607

Locations: 🇬🇷
University Hospital of Patras, Department of Anesthesiology, Patras, Achaia, Greece

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy